The Effect of Injectable Platelet-Rich Fibrin in Peri-implant Soft Tissue
Evaluation of the Effect of Injectable Platelet-Rich Fibrin on Peri-Implant Soft Tissue Phenotype
1 other identifier
interventional
80
1 country
1
Brief Summary
An inadequate amount of peri-implant soft tissue results in more plaque accumulation around the implants, peri-implant mucositis, marginal bone loss, mucosal recession, and/or attachment loss. In the literature, there are studies evaluating the application of injectable platelet-rich fibrin to the gingiva and oral mucosa around teeth, but injectable platelet-rich fibrin application around implants has not been encountered. This study aimed to evaluate the effect of subgingival and submucosal application of injectable platelet-rich fibrin on peri-implant soft tissue phenotype in patients with inadequate peri-implant soft tissue phenotype.The study will include 80 systemically healthy and non-smoking patients/implants older than 18 years of age with insufficient peri-implant keratinized mucosa width and mucosal thickness who applied to Kütahya University of Health Sciences, Faculty of Dentistry, Department of Periodontology. There are two study groups according to peri-implant mucosa phenotype: Thin phenotype and thick phenotype. All patients will undergo the same procedure of injectable platelet-rich fibrin application
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2022
CompletedFirst Submitted
Initial submission to the registry
November 26, 2024
CompletedFirst Posted
Study publicly available on registry
December 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2026
CompletedSeptember 11, 2025
September 1, 2025
3 years
November 26, 2024
September 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Peri-implant keratinized mucosa width
To measure peri-implant keratinized mucosa width of subgingival and submucosal injection of injectable platelet-rich fibrin in patients with inadequate peri-implant soft tissue phenotype at 1-year follow-up.
1-year follow-up of all implants
Peri-implant mucosa thickness
To measure peri-implant mucosa thickness of subgingival and submucosal injection of injectable platelet-rich fibrin in patients with inadequate peri-implant soft tissue phenotype at 1-year follow-up.
1-year follow-up of all implants
Secondary Outcomes (1)
Pink esthetic score
1-year follow-up of all implants
Study Arms (2)
Thin phenotype
OTHERMucosa thickness is less than 1 mm and the visibility of the probe in the sulcus is high.
Thick phenotype
OTHERMucosa thickness is greater than 1 mm and visibility of the probe in the sulcus is low.
Interventions
The injectable platelet rich fibrin will be integrated into the tissue by subgingival and submucosal application to the keratinized gingiva of the implant sites with insufficient peri-implant soft tissue phenotype. Then, the prepared injectable platelet rich fibrin will be injected into the mucogingival junction apical to the keratinized gingival site. This procedure will be repeated 3 times in total, 1 time in 30 days for 3 months.
Eligibility Criteria
You may qualify if:
- be over 18 years old
- The patient does not have any systemic disease
- Patients who do not smoke or who smoke less than 10 cigarettes
- Peri-implant keratinized mucosa width less than 2 mm
- Peri-implant mucosal thickness less than 2 mm
You may not qualify if:
- Being out of the defined age group
- Any systematic contraindication for periodontal surgery
- Patients who smoke more than 10 cigarettes per day
- Patients with adequate peri-implant keratinized mucosa width and mucosal thickness
- Pregnancy
- Patients taking medication that suppresses the immune system or impairs healing
- Patients taking medication that impairs the bleeding condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kütahya Health Sciences University Faculty of Dentistry
Kütahya, 43100, Turkey (Türkiye)
Related Publications (8)
Faour NH, Dayoub S, Hajeer MY. Evaluation of the Hyaluronic Acid Versus the Injectable Platelet-Rich Fibrin in the Management of the Thin Gingival Phenotype: A Split-Mouth Randomized Controlled Clinical Trial. Cureus. 2022 May 18;14(5):e25104. doi: 10.7759/cureus.25104. eCollection 2022 May.
PMID: 35607316BACKGROUNDOzsagir ZB, Saglam E, Sen Yilmaz B, Choukroun J, Tunali M. Injectable platelet-rich fibrin and microneedling for gingival augmentation in thin periodontal phenotype: A randomized controlled clinical trial. J Clin Periodontol. 2020 Apr;47(4):489-499. doi: 10.1111/jcpe.13247. Epub 2020 Feb 11.
PMID: 31912532BACKGROUNDMiron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, Choukroun J. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Investig. 2017 Nov;21(8):2619-2627. doi: 10.1007/s00784-017-2063-9. Epub 2017 Feb 2.
PMID: 28154995BACKGROUNDFrizzera F, Oliveira GJPL, Shibli JA, Moraes KC, Marcantonio EB, Marcantonio Junior E. Treatment of peri-implant soft tissue defects: a narrative review. Braz Oral Res. 2019 Sep 30;33(suppl 1):e073. doi: 10.1590/1807-3107bor-2019.vol33.0073. eCollection 2019.
PMID: 31576957BACKGROUNDBouri A Jr, Bissada N, Al-Zahrani MS, Faddoul F, Nouneh I. Width of keratinized gingiva and the health status of the supporting tissues around dental implants. Int J Oral Maxillofac Implants. 2008 Mar-Apr;23(2):323-6.
PMID: 18548930BACKGROUNDSchrott AR, Jimenez M, Hwang JW, Fiorellini J, Weber HP. Five-year evaluation of the influence of keratinized mucosa on peri-implant soft-tissue health and stability around implants supporting full-arch mandibular fixed prostheses. Clin Oral Implants Res. 2009 Oct;20(10):1170-7. doi: 10.1111/j.1600-0501.2009.01795.x. Epub 2009 Aug 30.
PMID: 19719741BACKGROUNDChung DM, Oh TJ, Shotwell JL, Misch CE, Wang HL. Significance of keratinized mucosa in maintenance of dental implants with different surfaces. J Periodontol. 2006 Aug;77(8):1410-20. doi: 10.1902/jop.2006.050393.
PMID: 16881810BACKGROUNDTavelli L, Barootchi S, Avila-Ortiz G, Urban IA, Giannobile WV, Wang HL. Peri-implant soft tissue phenotype modification and its impact on peri-implant health: A systematic review and network meta-analysis. J Periodontol. 2021 Jan;92(1):21-44. doi: 10.1002/JPER.19-0716. Epub 2020 Aug 9.
PMID: 32710810BACKGROUND
Study Officials
- STUDY DIRECTOR
Berceste Güler Ayyıldız, Assoc. Prof. Dr
Kütahya Health Sciences University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor Dr.
Study Record Dates
First Submitted
November 26, 2024
First Posted
December 31, 2024
Study Start
December 15, 2022
Primary Completion
December 15, 2025
Study Completion
April 15, 2026
Last Updated
September 11, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- The work will be shared 6 months after publication
- Access Criteria
- It will be shared in case the principal investigator is contacted.
Study Protocol Statistical Analysis Plan (SAP)